Macter expands Cobolmin range with sublingual option

MG News | December 22, 2025 at 03:55 PM GMT+05:00

0:00

December 22, 2025 (MLN): Macter International Limited (PSX: MACTER) introduced Cobolmin SL, a sublingual formulation of Mecobalamin.

The company stated that Cobolmin SL offers rapid absorption and enhanced convenience for patients through sublingual administration, the company’s filing on PSX revealed today.

The product expands the existing Cobolmin range, which includes tablets and injections, and underscores Macter International’s focus on innovation in healthcare.

At the time of writing, MACTER shares were trading at Rs 337.59, up 2.51 points, or 0.75%.

Copyright Mettis Link News

Related News

MTL expands Africa footprint with new export deal

PSX posts one of its strongest years on record

PSX Closing Bell: A Minor Setback

Name	Price/Vol	%Chg/NChg
KSE100	171,204.18 326.75M	-0.12% -200.31
ALLSHR	103,326.47 682.26M	-0.11% -115.78
KSE30	52,323.58 93.96M	-0.17% -90.21
KMI30	244,733.72 73.03M	0.04% 87.89
KMIALLSHR	67,164.58 409.64M	0.17% 114.30
BKTi	47,165.45 34.74M	-0.52% -248.09
OGTi	33,329.66 4.67M	-0.27% -90.09

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	90,090.00	90,190.00 87,910.00	2030.00 2.31%
BRENT CRUDE	61.68	61.77 60.53	1.21 2.00%
RICHARDS BAY COAL MONTHLY	91.00	0.00 0.00	2.30 2.59%
ROTTERDAM COAL MONTHLY	96.90	0.00 0.00	0.30 0.31%
USD RBD PALM OLEIN	1,016.00	1,016.00 1,016.00	0.00 0.00%
CRUDE OIL - WTI	57.67	57.77 56.60	1.15 2.03%
SUGAR #11 WORLD	14.92	14.99 14.83	0.10 0.67%